On August 28, 2017, Mirna Therapeutics, Inc., completed its business combination with Synlogic, Inc. The Form 8-K for Synlogic(NASDAQ ticker SYBX, cik0001667986) describes the transaction and was filed with the SEC on August 28, 2017. You can access the Form 8-K at the SEC’s Investor website:
(https://www.sec.gov/Archives/edgar/data/1281895/000119312517283239/d421363d8k.htm).
Read “Item 1.01, Entry into a Material Definitive Agreement” and determine which form of merger was used to affect the acquisition.